Edwards Lifesciences Corporation EW
86.29
0.56
0.65%
as of 25 Sep
- Market cap
- $49.4B
- P/E
- 49.6×
Follow EW
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Edwards Lifesciences Corporation (EW) Gross margin
Edwards Lifesciences Corporation's gross margin over the twelve months to 30 June 2026 was 77.8%, down 0.2 percentage points from fiscal 2025 (78.0%). Over the past ten years it has ranged from 73.1% (fiscal 2016) to 83.8% (fiscal 2022); the current reading is higher than 73% of that period. That is above the Medical Devices industry median of 56.0% and above the Healthcare sector median of 53.7%.
Gross margin, annual
Annual
| Period | Gross margin | Change (points) |
|---|---|---|
| FY2025 | 78.0% | (1.45) |
| FY2024 | 79.5% | (1.01) |
| FY2023 | 80.5% | (3.32) |
| FY2022 | 83.8% | 7.66 |
| FY2021 | 76.1% | 0.77 |
| FY2020 | 75.4% | 0.99 |
| FY2019 | 74.4% | (0.40) |
| FY2018 | 74.8% | 0.25 |
| FY2017 | 74.5% | 1.43 |
| FY2016 | 73.1% | (2.16) |
Quarterly
| Period | Gross margin | Change (points) |
|---|---|---|
| Jun 2026 | 77.5% | (0.55) |
| Mar 2026 | 78.0% | (0.14) |
| Dec 2025 | 78.2% | 0.38 |
| Sep 2025 | 77.8% | 0.25 |
| 42 more quarters | Free account |
Against its own ten years
Low 73.1%
High 83.8%
Ten-year median
75.4%
Current reading's percentile
73
Gross margin against peers
| Company | Gross margin |
|---|---|
| EW Edwards Lifesciences Corporation | 77.8% |
| BSX Boston Scientific Corporation compare | 69.9% |
| ZBH Zimmer Biomet Holdings, Inc. compare | 69.9% |
| MDT Medtronic PLC compare | 65.0% |
| SYK Stryker Corporation compare | 65.0% |
| DXCM DexCom, Inc. compare | 62.5% |
| PHG Koninklijke Philips N.V. compare | 45.9% |
| STE STERIS plc compare | 44.4% |
| GEHC GE HealthCare Technologies Inc. compare | 39.5% |
| Medical Devices industry median | 56.0% |
| Healthcare sector median | 53.7% |
| Market median | 46.3% |
What Gross margin is
Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.
Gross Profit ÷ Revenue
More on EW
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement